Mannose Receptor Targeting of Tumor Antigen pmel17 to Human Dendritic Cells Directs Anti-Melanoma T Cell Responses via Multiple HLA Molecules

Journal of Immunology

Volumn 172, Issue 5, 2004, Pages 2845-2852

  Ramakrishna, Venky ^a   Treml, John F ^a   Vitale, Laura ^a   Connolly, John E ^b,d   O'Neill, Thomas ^a   Smith, Patricia A ^a   Jones, Charles L ^a   He, Li Zhen ^a   Goldstein, Joel ^a   Wallace, Paul K ^c   Keler, Tibor ^a   Endres, Michael J ^a  

^a MEDAREX INC   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 100; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; MANNOSE RECEPTOR; MELANOMA ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B11; PROTEIN PMEL17; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ANTIGEN PRESENTATION; ARTICLE; CELL SPECIFICITY; COLD TARGETING; COLD TREATMENT; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; DOSE RESPONSE; ENDOCYTOSIS; EPITOPE MAPPING; GENETIC LINKAGE; HLA MATCHING; HLA SYSTEM; HUMAN; HUMAN CELL; INTERNALIZATION; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN TARGETING; RECEPTOR BINDING; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 10744226740     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.5.2845     Document Type: Article

References (44)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
2. Théry, C., and S. Amigorena. 2001. The cell biology of antigen presentation in dendritic cells. Curr. Opin. Immunol. 13:45.
3. Schuler, G., B. Schuler-Thurner, and R. M. Steinman. 2003. The use of dendritic cells in cancer immunotherapy. Curr. Opin. Immunol. 15:138.
4. Ramirez, M. C., and L. J. Sigal. 2002. Macrophages and dendritic cells use the cytosolic pathway to rapidly cross-present antigen from live, vaccinia-infected cells. J. Immunol. 169:6733.
5. Heath, W. R., and F. R. Carbone. 2001. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19:47.
6. Norbury, C. C., and L. J. Sigal. 2003. Cross priming or direct priming: is that really the question? Curr. Opin. Immunol. 15:82.
7. Morelli, A. E., H. Hackstein, and A. W. Thompson. 2001. Potential of tolerogenic dendritic cells for transplantation. Semin. Immunol. 13:323.
8. Jondal, M., R. Schirmbeck, and J. Reimann. 1996. MHC class 1-restricted CTL responses to exogenous antigens. Immunity 5:295.
9. Carayanniotis, G., and B. H. Barber. 1987. Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC. Nature 327:59.
10. Snider, D. P., and D. M. Segal. 1987. Targeted antigen presentation using crosslinked antibody heteroaggregates. J. Immunol. 139:1609.
11. Wallace, P. K., K. Y. Tsang, J. Goldstein, P. Correale, T. M. Jarry, J. Schlom, P. M. Guyre, M. S. Ernstoff, and M. W. Fanger. 2001. Exogenous antigen targeted to FcγRI on myeloid cells is presented in association with MHC class I. J. Immunol. Methods 248:183.
12. Regnault, A., D. Lankar, V. Lacabanne, A. Rodriguez, C. Théry, M. Rescigno, T. Saito, S. Verbeek, C. Bonnerot, P. Ricciardi-Castagnoli, et al. 1999. Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class 1-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189:371.
13. Dhodapkar, K. M., J. Krasovsky, B. Williamson, and M. V. Dhodapkar. 2002. Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific killer T cells by dendritic cells. J. Exp. Med. 195:125.
14. Selenko, N., O. Majdic, U. Jäger, C. Sillaber, J. Stöckl, and W. Knapp. 2002. Cross-priming of cytotoxic T cells by apoptosis-inducing tumor cell reactive antibodies? J. Clin. Immunol. 22:124.
15. Engering, A., T. B. H. Geijtenbeek, S. J. van Vliet, M. Wijers, E. van Liempt, N. Demaurex, A. Lanzavecchia, J. Fransen, C. G. Figdor, V. Piguet, et al. 2002. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol. 168:2118.
16. + T cell tolerance. J. Exp. Med. 196:1627.
17. Mahnke, K., M. Guo, S. Lee, H. Sepulveda, S. L. Swain, M. Nussenzweig, and R. M. Steinman. 2000. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J. Cell Biol. 151:673.
18. Prigozy, T. I., P. A. Sieling, D. Clemens, P. L. Stewart, S. M. Behar, S. A. Porcelli, M. B. Brenner, R. L. Modlin, and M. Kronenberg. 1997. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity 6:187.
19. Delneste, Y., G. Magistrelli, J.-F. Gauchat, J.-F. Haeuw, J.-P. Aubry, K. Nakamura, N. Kawakami-Honda, L. Goetsch, T. Sawamura, J.-Y. Bonnefoy, et al. 2002. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17:353.
20. Engering, A. J., M. Cella, D. Fluitsma, M. Brockhaus, E. C. M. Hoefsmit, A. Lanzavecchia, and J. Pieters. 1997. The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur. J. Immunol. 27:2417.
21. Tan, M. C., A. M. Mommaas, J. W. Drijfhout, R. Jordens, J. J. M. Onderwater, D. Verwoerd, A. A. Mulder, A. N. van der Heiden, D. Scheidegger, L. C. J. M. Oomen, et al. 1997. Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur. J. Immunol. 27:2426.
22. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:283.
23. Stahl, P. D., and R. A. B. Ezekowitz. 1998. The mannose receptor is a pattern recognition receptor involved in host defense. Curr. Opin. Immunol. 10:50.
24. Stahl, P., P. H. Schlesinger, E. Sigardson, J. S. Rodman, and Y. C. Lee. 1980. Receptor-mediated pinocytosis of mannose glycoconjugates by macrophages: characterization and evidence for receptor recycling. Cell 19:207.
25. Apostolopoulos, V., G. A. Pietersz, S. Gordon, L. Martinez-Pomares, and I. F. C. McKenzie, 2000. Aldehyde-mannan antigen complexes target the MHC class I antigen-presentation pathway. Eur. J. Immunol. 30:1714.
26. Apostolopoulos, V., and I. F. C. McKenzie. 2001. Role of the mannose in the immune response. Curr. Mol. Med. 1:469.
27. Clay, T. M., M. C. Custer, M. D. Mckee, M. Parkhurst, P. F. Robbins, K. Kerstann, J. Wunderlich, S. A. Rosenberg, and M. I. Nishimura. 1999. Changes in the fine specificity of gp100 209-217-reactive T cells in patients following vaccination with a peptide modified at an HLA-A2.1 anchor residue. J. Immunol. 162:1749.
28. Kawakami, Y., S. Eliyahu, C. Jennings, K. Sakaguchi, X. Kang, S. Southwood, P. F. Robbins, A. Sette, E. Appella, and S. A. Rosenberg. 1995. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol. 154:3961.
29. Kobayashi, H., J. Lu, and E. Celis. 2001. Identification of helper T-cell epitopes that encompass or lie proximal to cytotoxic T-cell epitopes in the gp100 melanoma tumor antigen. Cancer Res. 61:7577.
30. Lonberg, N., L. D. Taylor, F. A. Harding, M. Trounstine, K. M. Higgins, S. R. Schramm, C. C. Kuo, R. Mashayekh, K. Wymore, J. G. McCabe, et al. 1994. Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature 368:856.
31. Keler, T., P. M. Guyre, L. A. Vitale, K. Sundarapandiyan, J. G. van De Winkel, Y. M. Deo, and R. F. Graziano. 2000. Targeting weak antigens to CD64 elicits potent humoral responses in human CD64 transgenic mice. J. Immunol. 165:6738.
32. Ramakrishna, V., M. M. Ross, M. Petersson, C. C. Gatlin, C. E. Lyons, C. L. Miller, H. E. Myers, M. McDaniel, L. R. Karns, R. Kiessling, et al. 2003. Naturally occurring peptides associated with HLA-A2 in ovarian cancer cell lines identified by mass spectrometry are targets of HLA-A2-restricted cytotoxic T cells. Int. Immunol. 15:751.
33. Stahl, P. D. 1992. The mannose receptor and other macrophage lectins. Curr. Opin. Immunol. 4:49.
34. Magnusson, S., and T. Berg. 1993. Endocytosis of ricin by rat liver cells in vivo and in vitro is mainly mediated by mannose receptors on sinusoidal endothelial cells. Biochem. J. 291:749.
35. Noorman, F., E. A. Braat, M. Barrett-Bergshoeff, E. Barbe, A. van Leeuwen, J. Lindeman, and D. C. Rijken. 1997. Monoclonal antibodies against the human mannose receptor as a specific marker in flow cytometry and immunohistochemistry for macrophages. J. Leukocyte Biol. 61:63.
36. Dong, X., W. J. Storkus, and R. D. Salter. 1999. Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells. J. Immunol. 163:5427.
37. Lanzavecchia, A. 1996. Mechanisms of antigen uptake for presentation. Curr. Opin. Immunol. 8:348.
38. Mueller, A., E. Kelly, and P. G. Strange. 2002. Pathways for internalization and recycling of the chemokine receptor CCR5. Blood 99:785.
39. Kwon, B. S., C. Chintamaneni, C. A. Kozak, N. G. Copeland, D. J. Gilbert, N. Jenkins, D. Barton, U. Francke, Y. Kobayashi, and K. Kim. 1991. A melanocyte-specific gene, pmel 17, maps near the silver coat color locus on mouse chromosome 10 and is in a syntenic region on human chromosome 12. Proc. Natl. Acad. Sci. USA 88:9228.
40. Kawakami, Y., P. F. Robbins, R. F. Wang, M. Parkhurst, X. Kang, and S. A. Rosenberg. 1998. The use of melanosomal proteins in the immunotherapy of melanoma. J. Immunother. 21:237.
41. Kim, C. J., S. Dessureault, D. Gabrilovich, D. S. Reintgen, and C. L. Slingluff 2002. Immunotherapy for melanoma. Cancer Control 9:22.
42. Crowley, M., K. Inaba, and R. M. Steinman. 1990. Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins. J. Exp. Med. 172:383.
43. Mellman, I., and R. M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106:255.
44. Hawiger, D., K. Inaba, Y. Dorsett, K. Guo, K. Mahnke, M. Rivera, J. V. Ravetch, and R. M. Steinman. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:769.